https://it.marketscreener.com/quotazioni/azione/TFF-PHARMACEUTICALS-INC-69391266/attualita/TFF-Pharmaceuticals-Inc-annuncia-i-dati-aggiornati-dei-programmi-clinici-Tacrolimus-Polvere-Inalat-46307920/?utm_source=telegram&utm_medium=social&utm_campaign=share